At the same time, albumin level is affected by various confounding factors; the decrease in albumin level in patients with end-stage tumors can be due to anorexia, malnutrition, gastrointestinal dysfunction, absorption disorder, tumor cachexia, dysfunction of the liver and kidney, metabolic disorder, and systemic inflammatory reaction. This evidence concerns the gene ALB and metabolic disease.